Although the mechanisms regulating distinct effects of PIK3R1/p50α in modulating Akt activation in mouse mammary epithelial cells and human breast cancer cells remain to be further delineated, this study supports that different PIK3R1 variants (p85, p55 and p50) could be transcriptionally regulated by variant-specific promoters. Here, NFKB1 is linked to breast cancer.